(Q38045763)

English

Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration

scientific article published on 21 September 2012

Statements

Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit